Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 20.24
+0.02 (0.10%)
Mar 30, 2026, 4:00 PM EDT
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.23 billion as of March 30, 2026. Its market cap has decreased by -16.84% in one year.
Market Cap
2.23B
Enterprise Value
1.65B
Revenue
193.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.24
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.23B, a decrease of -45.25%. That is a compound annual growth rate of -16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 2.23B | -15.07% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 2.79B |
| Shanghai Serum Bio-Technology | 2.75B |
| Shandong Sito Bio-technology | 2.69B |
| Jilin Jian Yisheng Pharmaceutical | 2.67B |
| Shanghai Universal Biotech | 2.60B |
| Hubei Goto Biopharm | 2.38B |
| Zhejiang East Asia Pharmaceutical | 2.38B |
| Guiyang Xintian Pharmaceutical | 2.36B |